Australia, Nov. 11 -- Bristol-Myers Squibb Co., owns the trademark (2580948) for 'LIBHAYLZ' till Aug. 27, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders.] and 5 [All items in this class are claimed in the convention application.]
Type of Mark: Word
Date of Acceptance: Sept. 3
Registration Advertised: Nov. 10
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2580948.
Disclaimer: Curated by HT Syndication.
